MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.390
+0.010 (0.72%)
Jul 10, 2026, 4:00 PM EDT - Market closed
MediciNova Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 27.33 | 30.81 | 40.36 | 51 | 18.51 | 71.43 |
Short-Term Investments | - | - | - | - | 39.98 | - |
Cash & Short-Term Investments | 27.33 | 30.81 | 40.36 | 51 | 58.49 | 71.43 |
Cash Growth | -25.27% | -23.67% | -20.86% | -12.80% | -18.12% | 18.98% |
Accounts Receivable | 0.25 | - | - | - | - | - |
Other Current Assets | 0.57 | 0.18 | 0.71 | 0.17 | 0.5 | 0.58 |
Total Current Assets | 28.15 | 30.99 | 41.07 | 51.17 | 58.99 | 72.01 |
Net Property, Plant & Equipment | 0.16 | 0.19 | 0.38 | 0.62 | 0.67 | 0.88 |
Other Intangible Assets | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 |
Goodwill | 9.6 | 9.6 | 9.6 | 9.6 | 9.6 | 9.6 |
Other Long-Term Assets | - | 0.02 | 0.02 | 0.07 | 0.09 | 0.12 |
Total Assets | 42.7 | 45.6 | 55.88 | 66.27 | 74.15 | 87.41 |
Accounts Payable | 0.85 | 0.62 | 1.1 | 1 | 0.42 | 0.4 |
Accrued Expenses | 1.65 | 2.61 | 1.66 | 2.06 | 2.61 | 2.3 |
Current Portion of Leases | 0.17 | 0.19 | 0.19 | 0.22 | 0.16 | 0.13 |
Unearned Revenue | 0.43 | 0.37 | - | - | - | - |
Total Current Liabilities | 3.1 | 3.8 | 2.96 | 3.28 | 3.19 | 2.83 |
Other Long-Term Liabilities | 0.2 | 0.22 | 0.41 | 0.61 | 0.73 | 0.9 |
Total Long-Term Liabilities | 0.2 | 0.22 | 0.41 | 0.61 | 0.73 | 0.9 |
Total Liabilities | 3.3 | 4.02 | 3.37 | 3.89 | 3.91 | 3.73 |
Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Additional Paid-in Capital | 480.82 | 480.41 | 479.34 | 478.15 | 477.44 | 476.79 |
Accumulated Other Comprehensive Income | -0.13 | -0.13 | -0.14 | -0.12 | -0.12 | -0.1 |
Retained Earnings | -441.34 | -438.75 | -426.75 | -415.7 | -407.13 | -393.06 |
Shareholders' Equity | 39.41 | 41.59 | 52.5 | 62.38 | 70.24 | 83.68 |
Total Liabilities & Equity | 42.7 | 45.6 | 55.88 | 66.27 | 74.15 | 87.41 |
Total Debt | 0.17 | 0.19 | 0.19 | 0.22 | 0.16 | 0.13 |
Net Cash (Debt) | 27.16 | 30.61 | 40.17 | 50.78 | 58.33 | 71.3 |
Net Cash Growth | -11.26% | -23.79% | -20.91% | -12.94% | -18.19% | 19.13% |
Net Cash Per Share | 0.55 | 0.62 | 0.82 | 1.03 | 1.19 | 1.47 |
Book Value | 39.41 | 41.59 | 52.5 | 62.38 | 70.24 | 83.68 |
Book Value Per Share | 0.80 | 0.85 | 1.07 | 1.27 | 1.43 | 1.72 |
Tangible Book Value | 25.01 | 27.19 | 38.1 | 47.98 | 55.84 | 69.28 |
Tangible Book Value Per Share | 0.51 | 0.55 | 0.78 | 0.98 | 1.14 | 1.43 |